PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 14 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous leaf extract (ALE) significantly increased reaction time in hot plate tests (84-121% increase at high dose) and impaired licking behavior in formalin tests in rats [PMID:15652286].
Pratorinine, 6 alpha-hydroxybuphanisine, and 4'-hydroxy-7-methoxyflavan showed moderate to important cytotoxic activity in vitro [PMID:1798796].
In silico screening identified the plant as a source of compounds that are potential inhibitors of anti-diabetic drug targets [PMID:31137754].
Evidence summary
PubMed sources
- 1.PMID: 38202387 (2023) — Crinum bulbispermum, a Medicinal Geophyte with Phytostabilization Properties in Metal-Enriched Mine Tailings. · Plants (Basel, Switzerland)
- 2.PMID: 1798796 (1991) — Cytotoxic activity of Amaryllidaceae alkaloids from Crinum augustum and Crinum bulbispermum. · Planta medica
- 3.PMID: 15652286 (2005) — Leaf extract of Crinum bulbispermum has antinociceptive activity in rats. · Journal of ethnopharmacology
- 4.PMID: 17340344 (1984) — Alkaloidal Constituents of Crinum bulbispermum III: Bulbispermine, a New Alkaloid of Crinum bulbispermum1. · Planta medica
- 5.PMID: 11014284 (2000) — Minor phenolics from Crinum bulbispermum bulbs.